Your browser doesn't support javascript.
loading
FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.
Zhang, Yuan; Edgley, Amanda J; Cox, Alison J; Powell, Andrew K; Wang, Bing; Kompa, Andrew R; Stapleton, David I; Zammit, Steven C; Williams, Spencer J; Krum, Henry; Gilbert, Richard E; Kelly, Darren J.
Affiliation
  • Zhang Y; Department of Medicine, St Vincent's Hospital, University of Melbourne, Australia.
Eur J Heart Fail ; 14(5): 549-62, 2012 May.
Article in En | MEDLINE | ID: mdl-22417655

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Caffeic Acids / Myocytes, Cardiac / Diabetes Mellitus, Experimental / Diabetic Cardiomyopathies / Ortho-Aminobenzoates / Heart Failure / Myocardium / Antifibrinolytic Agents Type of study: Etiology_studies Limits: Animals Language: En Journal: Eur J Heart Fail Journal subject: CARDIOLOGIA Year: 2012 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Caffeic Acids / Myocytes, Cardiac / Diabetes Mellitus, Experimental / Diabetic Cardiomyopathies / Ortho-Aminobenzoates / Heart Failure / Myocardium / Antifibrinolytic Agents Type of study: Etiology_studies Limits: Animals Language: En Journal: Eur J Heart Fail Journal subject: CARDIOLOGIA Year: 2012 Document type: Article Affiliation country: Australia